| Name | Title | Contact Details |
|---|
Katon Partners is a Rye, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Uroplasty is a global medical company committed to offering transformative treatment options through specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Uroplasty’s products include the Urgent® PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Urgent PC is an FDA-cleared system that delivers PTNS (Percutaneous Tibial Nerve Stimulation) and is also indicated for the treatment of fecal incontinence outside the US market. Uroplasty also offers Macroplastique®, an injectable urethral bulking agent for female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Female SUI only in U.S.; male and female SUI outside the U.S. Uroplasty products are typically used when a patient’s treatment goals are not met after conservative and/or drug therapies. Providers and patients alike appreciate that Uroplasty products provide low-risk, effective alternatives to invasive surgery. And because these treatments can be delivered in an office or outpatient setting, the end result is that more patients are given the opportunity to transform their lives with successful treatment.
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.
As one of Western New York`s first HMOs, Independent Health covers over 365,000 people here and across the country with more than 100 plans, services and products. If you have any questions about your Independent Health account, feel free to contact us through one of the following links: Members - Contact Member Services for questions regarding your Independent Health plan, benefits, doctor information, etc. You may also use this link if you are having problems logging into our online system. FSA Members - Contact the FSA Department for questions regarding your FSA Account information. You may also use this link if you are having problems logging into our online system. Healthcare Professionals/Providers - Provider or Health Care offices may contact Provider Relations for billing inquiries, requests to become participating providers, or for general questions. Employers - Contact Employer Relations Brokers - Contact Broker Sales
Pronger Smith Medical Care's 60 year tradition of trust and service offers you and your family a unique approach to health care. We are fully equipped to provide a lifetime of comprehensive and accessible care-all under one roof. This continued effort